Try our Advanced Search for more refined results
Life Sciences - November, 2016
314 articles
- Elan Investors Seek Initial OK For $135M SAC Capital Deal
- Ex-DePuy Exec Asks 11th Circ. To Reverse Noncompete Ban
- Plaintiffs Seek Big Punitives In 3rd J&J Hip Implant Trial
- LifeNet Seeks $17M Interest After 2014 $35M Patent Win
- Male Sex Enhancement Supplement Recalled
- Judge Drops 24 Knee Implant Cases From Zimmer MDL
- Bill On FDA Approvals, Mental Health Policy Clears House
- Life Tech Tells Justices Quantity Matters In Patent Case
- The Ethical Risks Of A Multijurisdictional Practice
- Malpractice Suit Says Allergan Schemed With Implant Doctors
- PE Investors Plug $260M Into China's Innovent Biologics
- Deals Rumor Mill: Johnson & Johnson, AppNexus, Albertsons
- Bombay Court Won't Send Contract Row To Arbitration
- Doc In $20.3M Patent Suit Slams Claim He Withheld Evidence
- Braintree Labs Fights Ferring False Ad Trial Delay
- Phase-Down Of HFCs Depends On Trump Administration
- 3rd Circ. Won't Rethink Mylan's Doryx Product-Hopping Loss
- Boston Scientific Hit With IP Suit Over Pain Treatment Tech
- 3 Key Takeaways Buried In 1st Circ.'s Nexium Ruling
- Lidoderm Buyers, Payors Near Cert. In Pay-For-Delay MDL
- Herbalist Says Las Vegas Company Infringing Trademarks
- Illumina Can Add Patent To DNA Sequencer Infringement Case
- J&J Unlikely To Cut Risperdal Deals As Appeals Play Out
- Gov't To Ask If Chemical Weapons Treaty Affects Businesses
- FDA Warning Wire: Grimy Galleys On Riverboats
- Whistleblower In $785M Pfizer FCA Deal Agrees To Fees Split
- 11th Circ. Faults Service Delay In Tossing J&J Hip Suit
- And Now A Word From The Panel: MDL Venue Choices
- Intuitive Can Be Sued For Stolen Da Vinci Robot Payments
- How Law Firms Are Using Analytics To Reduce Write-Offs
- Doctor Defends Sanofi TCPA Suit From Claims It's Untimely
- Deals Rumor Mill: Johnson & Johnson, WGL Holdings, Avaya
- A Review Of Key Cases Against Executives In Q3
- A Look At The On-Sale Bar: Part 2 — Best Business Practices
- $2.75M Deal Settling 9-Year-Old Amgen ERISA Suit Nears OK
- 1st Circ. Revives Part Of Securities Suit Against Ariad
- PharMerica Escapes Federal FCA Claims Over Kickbacks
- Theranos Stuck By Investor Suit Saying It Lied About Testing
- Celgene Wants PTAB Rethink On Bass' Cancer Drug IP Win
- Theranos Wants Most Claims Tossed In $96M Hedge Fund Suit
- Kimberly-Clark's Stay Bid Assailed In Surgery Gown Suit
- Post Unit Hit With False Ad Suit Over Joint-Health Products
- Antibody Drug Developer Kymab Snags $100M From Investors
- GCs Say This Firm Is The Most Arrogant
- A Look At The On-Sale Bar: Part 1 — The Helsinn Debate
- In Congress: 3 Priorities
- The Missing American Jury
- Bio-Rad Says Ex-GC Faked FCPA Concerns To Save Job
- Idenix, Gilead To Battle Over Hepatitis IP At Trial
- 6th Circ. Denies Payment Bid In Dow Corning Implant Deal
- Acorda, AstraZeneca Tell Justices To Skip ANDA Venue Case
- Eli Lilly Abandons Alzheimer's Drug After Failed Trial
- PTAB Invalidates Claims In Durezol Eye Drops Patent
- 3rd Circ. Won't Review Atty Sanctions In Fish Oil Suit
- Sheller PC Wants 3rd. Circ. To Rehear Risperdal Row
- EU OKs Abbott's $25B Acquisition Of St. Jude With Caveats
- No 3rd Circ. Rehearing In Zimmer Hip Replacement Case
- Investcorp Drops $250M On Boston, Denver Properties
- Employer Takeaways From Abbott's $4.25M Age-Bias Verdict
- Neovasc Escapes Investor Suit Over $70M Trial Loss
- Shkreli Atty Rips Retrophin Over Katten Doc Privilege Row
- 1st Circ. Won't Revive Takeda FCA Actos Kickbacks Suit
- Actavis Infringed Orexo's Zubsolv Patent, Del. Judge Rules
- FDA Warning Wire: Peanut Allergy Claims Get A Shellacking
- INTA Pushes High Court To Take Flanax Trademark Case
- Consumer's False Ad Suit Falls Flat, Supplement Maker Says
- On Second Thought, Court Drops UBS From Defamation Suit
- Consumers Says Nivea Can't Slip Out Of Lotion Suit
- Ala. Justices Trim Pharmacy's Tainted-Drug Coverage By $3M
- Expert OK To Testify In GSK Suit By Reed Smith Atty's Widow
- Arch Venture Partners Seeks $550M With Upsized Fund Target
- J&J Wants Philly Invokana Cases In NJ Federal Court
- Plumlee V. Pfizer: Don't Underestimate Statute Of Limitations
- Law360 MVP Awards Go To Top Attorneys From 76 Firms
- 8 States Have Legalized Marijuana In 8 Different Ways
- Avoiding Law Firm BYOD Risks: Tips For Securing Devices
- Female Condom Co. Merged Without Investors' OK, Suit Says
- 1st Circ. Won't Revive Nexium Pay-For-Delay Suit
- Mylan, Par, Others Rigged Divalproex Sodium ER Prices: Suit
- Shkreli's Ex-Atty Wants Detailed Charges, Citing Gov't Error
- Mylan Refuses To Testify At Senate's EpiPen Rebate Hearing
- Fla. Doctor Convicted Of Using Foreign, Unlicensed Drugs
- Kimberly-Clark Seeks To Freeze Gown Trial For Cert. Appeal
- Antitrust Agencies Can Curb High Prices, Vestager Says
- Merger Control Update: It Ain't Over Till It's Over
- 4 Ways Lawyers Can Improve Their Marketing
- What To Expect In The Remaining Days Of The 114th Congress
- GSK, Others Back Bristol-Myers In Plavix Jurisdiction Row
- 6th Circ. Axes Stryker's $8.6M Knee Implant Coverage Win
- Adapt Pharma Urges FDA Hurdles For Teva Overdose Generic
- Thermolife Bristles at 'Patent Troll' Label In Amino Patent Suit
- Sessions' History Is Short But Not Silent On Antitrust
- Health Hires: Merchant & Gould, Davis Wright, Greenspoon
- Medical Robotics Co. Myomo Plans 'Mini-IPO'
- FDA Pauses Stronger Lab Test Oversight
- Taxation With Representation: Wachtell, Kirkland, Simpson
- 6 More States Join Suboxone Product-Hopping Lawsuit
- FDA Weighs Pros And Cons Of Off-Label Promotion
- Beyond Bean Counting: How Legal Can Add True Value
- The Unintended Impact Of DEA's New Registration Policy
- Procaps Wants Antitrust Suit Over $255M Merger Revived
- Amgen Investor Defends Decade-Old Derivative Suit
- Pfizer Sues Texas Agency For Releasing Drug Rebate Info
- Fed. Circ. Affirms Generics' Win In Kidney Drug Patent Suit
- Hearing Aid Patent Case Sent Back By Fed. Circ. Under Halo
- Ardian Enters Exclusive Talks To Acquire Unither Pharma
- Chicago Passes Strict Licensing Standards For Pharma Reps
- Labaton Attys Used False Witness Statements, Intuitive Says
- Judge Nixes Some Claims In Meningitis Outbreak Litigation
- Duane Morris & Selvam Taiwan Opens In Taipei
- Pharmacist Admits Running $2.4M Prescription Fraud Scheme
- GSK Defends Suicide Expert In Trial Over Reed Smith Death
- Apotex Pushes To Have Late Sandoz Subpoena Tossed
- Bharara Unveils Charges Against Ex-Valeant, Philidor Execs
- Ex-Amerisource Employee Claims Its Lies Cost Him Jobs
- Vitamin Buyers Try Again On False 'Made In USA' Cert. Bid
- Stock, Screen, Steer, Substitute To Win Bellwether Trials
- Patients Want 2 UnitedHealth Clawback Suits Combined
- Post-Election Thoughts On Antitrust
- OPINION: The US Supreme Court In 2017
- Shkreli Says Retrophin Has Waived Privilege For Katten Docs
- 9th Circ. Backs $15M Medtronic Verdict Over Pabban Deal
- Teva Beats Merck Infringement Suit Over Valid Patent
- Whistleblowers Fight To Revive Medicare Suit In 11th Circ.
- Senator Wants DOJ To Testify At EpiPen Rebate Hearing
- Pharmacist Facing Murder Charges Seeks MDL Docs
- Affordable Drug Group Blasts Pozen Patent At PTAB
- Zuckerman Spaeder Nabs Obama's Ex-Top Health Atty
- Simpson Thacher Leads Banks In Samsung Biologics' $2B IPO
- Work For GSK Got Pair Jailed In China, Suit Says
- FTC Aims To Be Stricter On Homeopathic Medicine Claims
- UnitedHealth Sued Again Over Prescription Copay Clawbacks
- Teva Pharmaceuticals Earmarks $520M To End FCPA Claims
- FDA Draft Sheds Light On Software As A Medical Device
- A Primer On The Presidential Appointee Vetting Process
- Merging Law Firms: Think Before You Tie The Knot
- Abbott, Alere Report Records Deal But Merger Issues Linger
- Once Sizzling, Silicon Valley Venture Financings Level Out
- FDA Warning Wire: Gripes Over Gluten, Deleted Data
- Fed. Circ. Says PTAB Wrongly Invalidated Surgical Patent
- Medical Supply Company Collars $1.2M Patent Judgment
- Kimberly-Clark Headed Toward Trial In Surgery Gown Suit
- SEC Settles Insider Trading Suit Against Ex-FDA Official
- Deals Rumor Mill: Snapchat, Viacom, Abbott Laboratories
- PTAB Upholds Patent In A First For Post-Grant Reviews
- How A Trump Administration Might Affect Product Liability
- Consumers Say GNC Can't Trash 'Slack Fill' Suit
- What's Next For US-Mexico Bilateral Trade Under Trump?
- Ex-Forest Sales Rep Defends Counsel In Namenda FCA Suit
- Zimmer Wants 142 Knee Cases Without Expert Reports Cut
- Merging Law Firms: Why Deals Fail Or Underperform
- Jury Hands Doctor $20.3M Verdict In Medtronic Patent Suit
- Alice Rejections Frustrating Patent Applicants, USPTO Told
- Merck Says Public Info Bars Whistleblower's Kickback Case
- PTAB Nixes Biosimilar Co.'s Bid For AbbVie Humira Review
- Mom Says Mo. Appeals Ruling Backs Her Depakote Claims
- Justices Won't Hear Drugmakers' OxyContin Patent Appeal
- Diplomat Pharmacy Faces Shareholder Suit Over Value Drop
- Cephalon, Teva Slam Pa. Opioid Off-Label Marketing Suit
- Deals Rumor Mill: Reynolds American, Novartis, AB InBev
- FCPA Enforcement On Near-Record Pace For 2016: Part 2
- Intellectual Property Under A Donald Trump Presidency
- What To Expect From The New Senate
- Impax Investor Says Drug Price-Fixing Probe Never Disclosed
- SEC Wins Insider Trading Trial Of Ex-InterMune Director
- Vitamin Health's False Ad Fight Not Covered, 6th Circ. Told
- 3rd Circ. Asked To Rehear Zimmer Hip Replacement Case
- Merging Law Firms: Beware Conflicts Of Interest
- Class Action Over Hep C Coverage Falls Flat, Colo. Says
- Man Vs. Machine: Or, Lawyers Vs. Legal Technology
- OPINION: The Verdict — A Rejection Of Politics As Usual
- Siemens Readies Public Listing For Health Care Unit
- Patent Legislation Has Uncertain Path In Trump Presidency
- Halo Applies To Trans Ova IP Suit, Judge Rules
- SEC Accused Of Race Profiling As Insider Trade Trial Ends
- McConnell Wants 21st Century Cures Act Passed In 2016
- GSK Seeks Sanctions Against Payors Quitting Avandia MDL
- Judge Will Hear GSK's Arguments To Dismiss Zofran MDL
- Amphastar Asks 9th Circ. To Revive Sanofi Patent FCA Suit
- Merging Law Firms: Why Hogan Lovells Has Worked
- Judge Gives Final OK To $3.3M Deal In Roka IPO Row
- Wright Beats Metal-Artificial-Hip Suit In Missouri
- Marijuana Tipping Point: California And Florida Lead The Way
- GSK Can't Duck Insurers' RICO Suit
- Benicar MDL Judge Says Docs Don't Show Cause Of Injuries
- 5 Takeaways From FDA's Off-Label Promo Forum
- Monkey Blood Supplier Pleads Guilty To False Labeling
- SEC Tells Jury Evidence Shows InterMune Exec Tipped Pal
- $15M Deal To End Adderall Buyers' Class Action Wins OK
- EU OKs Boehringer Animal Health Biz Buy, With Conditions
- Fed. Circ. Says PTAB Violated Process In NuVasive Review
- Czech Republic Takes $325M Blood Award To Supreme Court
- Pfizer Nabs 9th Circ. Victory In Zoloft False-Ad Suit
- FDA Will Study Drug Risk Info On Social Media
- Trial Ordered In Cryo-Chamber Arbitration Clause Row
- Pa. Man Gets Year For Role In $1.2M Embezzlement Scheme
- Pfizer Slams Appeal In Off-Label FCA Case In 1st Circ.
- Chamber Of Commerce, IRS Clash On Anti-Inversion Rule
- Impax Case Dies With Endo Pay-For-Delay Suit, FTC Says
- Animal Co. Gets PTAB Review Of Flea, Tick Treatment Patent
- Katten Muchin In Privilege Danger Zone With Shkreli Doc Bid
- Pharmacy Execs Linked To Meningitis Outbreak Get Probation
- GE's Barnes & Thornburg DQ Bid Is Misdirection, Court Told
- Calif. Voters Reject Measure To Limit Gov't Drug Costs
- Pharmacists Blast Feds' Bid For Redo In Meningitis Case
- Lab's Billing Claim Stiffed Marketers, Pa. Class Suit Says
- FCPA Enforcement On Near-Record Pace For 2016: Part 1
- Upcoming High Court Patent Decisions May Not Affect Stocks
- Trump's Upset Win Puts Obama Legacy On Chopping Block
- After Trump's Triumph, What's Next?
- Trump Win Puts These 4 On High Court Shortlist
- GOP Retains Control Of Both Houses Of Congress
- Marijuana Ballots: Calif., Fla. Say Yes To Legal Pot
- Walgreens Hits Theranos With $140M Breach Of Contract Suit
- AMS Sanctioned Over Subpoenas In Pelvic Mesh MDL
- 10 Cases Picked For Next Bellwether In J&J Artificial Hip MDL
- 'Secondhand' Info Sinks Whistleblower's FCA Suit At 11th Circ.
- Senate Leaders Press 2 Fed. Agencies For EpiPen Reviews
- Pot Grower Can't Nix Tax Ruling On 5th Amendment Grounds
- Kyle Bass Praises PTAB Nix Of 'Absurd' Drug Patents
- Mylan Floats Biosimilar Of Mega-Blockbuster Herceptin
- Ex-Cyberonics Sales Rep Asks 1st Circ. To Revive FCA Case
- Shareholders Sue Cempra Over Pneumonia Drug Safety
- FTC Wins Dismissal Of Opana, Lidoderm Pay-For-Delay Suit
- SC Judge Says 70 Lipitor Suits Should Go Back To Calif.
- Nev. Judge Shuts Down Trump's Early Voting Suit
- The Firms Cashing In This Election Season
- Why The Candidates' BigLaw Bills Keep Rising
- Candid Advice From The Bench: Judges Are People Too
- Fed. Circ. Upholds Endo's PTAB Win In Amneal Patent Fight
- FTC Asks 1st Circ. To Reverse Momenta Antitrust Win
- How New EPA Hazardous Waste Rule Impacts Retail Pharmacies
- Brexit And Supplemental Protection Certificates
- NuScience Says Atty's Vow To 'Destroy' Co. Shows Malice
- Takeda Asks 1st Circ. Not To Revive Actos Kickback Suit
- Valeant To Pop Out Paragon To Quell FTC Antitrust Concerns
- CEO Of Defunct Pharma Co. Sued For $489K Russian Award
- Novartis Unit Engineers Seek Cert. In FLSA Classification Row
- Endo Faces Securities Suit Over Unit's Price-Fixing Probe
- Hyman Phelps Attacks FDA Over 'Broken Approval System'
- Justices' Guidance Still Needed On Pay-For-Delay Accords
- Citizens United Architect Predicts Future Finance Battles
- Clinton Trounces Trump In Donations From Biggest Of BigLaw
- Justices Won't Consider IP Suit Over Amylin Drug Promos
- Pakistani Nationals Sentenced In Drug-Shipping Scheme
- Senators Want Mylan To Pay DOD $50M In EpiPen Refunds
- Minn. Right For Provigil Pay-For-Delay Suit, United Says
- 7 Steps For Managing An Associate Who May Be Impaired
- Calif. Org. Cut Auritec Out Of HIV Research, Suit Says
- J&J Can't Boot Invokana Injury Case From Pa. Court
- High Court Won't Review Lamictal Pay-For-Delay Row
- Trump Vs. Clinton: Some Antitrust Predictions
- Couple Convicted After Meningitis Outbreak Ask For Probation
- FDA Panel Votes For Pneumonia Antibiotic Approval
- Fla. Attys Get The Buzz On Entering Cannabis Law Field
- Benefits Manager Escapes Blue Cross Hep C Coverage Suit
- NJ Bill Would Ban Drug Coupons When Generics Exist
- Deals Rumor Mill: Warburg Pincus, Arrium, Endo International
- 3 Firms To Lead IPOs Totaling $80M As Election Slows Deals
- Ex-Greene LLP Partner Says Firm Owes Him Millions
- Katten Says Slew Of Sought Shkreli Docs Likely Privileged
- Health Hires: Hall Render, Lewis Brisbois, DeCotiis
- Lawmakers Call On Feds To Investigate Insulin Pricing
- Law Confusion No Reason To Ax Meningitis Suits, Court Told
- 2nd Circ. Won't Rehear Vitamin C Antitrust Decision
- Learned Intermediary Rule Prevails In Wisconsin Decision
- Brand Battles: Wal-Mart, Bristol-Myers, Adidas, FC Barcelona
- Health Care Provider Says Pharma Cos. Fixed Saline Prices
- FDA Inspectors Letting Loose On Defiant Drugmakers
- PTAB Upholds Patent For Horizon's Urine Disorder Drug
- Sloan-Kettering Says Niro Attys Filched Gene Therapy Docs
- Avalanche Biotechnologies Escapes IPO Suit Over Eye Drug
- The Role Of Litigation Analytics In Your Case
- Rainmaker Q&A: Schiff Hardin's Imron Aly
- Lipitor Users Say Diabetes Claims Belong In Calif. Court
- DC Circ. Won't Revisit Takeda's Gout Drug Dispute With FDA
- Chamber Of Commerce Backs GSK In 3rd Circ. Drug Appeal
- Abbott Offers Fixes To Clear $25B St. Jude Deal In EU
- Novartis Asks Fed. Circ. To Revive MS Treatment Patent
- Amneal Fights Endo's PTAB Win At Fed. Circ.
- FDA Scolds Supernus Pharmaceuticals Over Video Claims
- Spinning Off In The Biotech And Pharmaceutical Industries
- Green Coffee Adman Must Disgorge $29M In Fake Ad Suit
- 2nd Circ. Backs Ban On 'Gray Market' Sale Of Abbott Test Strip
- Employees Can't Trim RICO Claims In Meningitis Outbreak Suit
- 'Made In USA' Vitamin Buyer's Class Cert. Bid Too Long
- OPINION: 3rd Circ. Should Rehear Product-Hopping Case
- Adapt Or Die: Law Firms In Tomorrow's Economy — Part 5
- Mylan's EpiPen Rebate Deal Is Unacceptable, W.Va. AG Says
- Wright Medical Technology Agrees To $240M Hip Implant Deal
- Valeant Hit With Chancery Suit Over Libido Drug Marketing
- Deals Rumor Mill: Valeant, Fujifilm, Takata
- Lipitor Diabetes Suits Against Pharmacy Booted From MDL
- New Developments In The Missouri Removal Wars
- ITC Judge Says Swedish Co.'s Radiotherapy Imports Flout IP
- 2016's Thriving M&A Market
- J&J Settlement Ends Latest Pa. Risperdal Case Before Trial
- Fed. Circ. Urged To Reinstate Stanford Fetal Testing Patent
- Valeant Confirms Salix Is Up For Sale
- 4 Ways To Get Associates Trial-Ready
- Adapt Or Die: Law Firms In Tomorrow's Economy — Part 4
- Bayer, Pfizer Agree To Judge's Deal In Bovine Drug IP Row
- Justices Question Viability Of Laches Defense In Patent Law
- Deals Rumor Mill: Valeant, Mubadala, Amtek
- Express Scripts Wants Pharmacies To Back Up Antitrust Suit
- U of Wis. Backs Promega In Patent-Export High Court Case
- FDA Warning Wire: Officials Blocked From Chinese Drug Plant
- Ex-Insys Manager Says Drug Testing Him Is Unconstitutional
- Pfizer Wants 15 Non-Calif. Plaintiffs Out Of Zoloft MDL
- Feds Can't Escape Pfizer's $8.3M Tax Refund Interest Suit
- Momenta Must Face Clot Drug Antitrust Row, 1st Circ. Told
- Drugmaker Wins Reconsideration Bid In Toxic Exposure Suit
- Adapt Or Die: Law Firms In Tomorrow's Economy — Part 3
- When Your Client Is The President: Part 8